Key facts
- DiappyMed’s last known valuation is $2.9M (Jul 2023).
- It has raised $6.2M; the latest was Seed Round ($5.8M) in Mar 2026.
- Notable investors include Ventech (Paris), IRDI Capital Investissement, Sofilaro, AFI Ventures, Business & Innovation Center — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for DiappyMed
- ·The full record, as it builds
Funding rounds
No funding rounds for DiappyMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DiappyMed
Developer of a digital health platform designed to provide intelligent and personalized insulin dosing. The company's platform calculates insulin dosage based on inputs such as current blood sugar levels, planned meals, and physical activity, enabling individuals to enhance the daily management of diabetes.
- Sector
- Healthcare
- HQ
- Clapiers, France
- Founded
- 2021
- Employees
- 15
- Website
- diappymed.com/
- Ownership
- Privately Held (backing)
DiappyMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DiappyMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DiappyMed in its N-PORT filings yet. We sweep new filings monthly.